US Broker Ratings

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 46% Upside Potential Beckons Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is capturing the attention of investors with its compelling growth story and potential for significant upside. As a leading player in..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 18.16% Upside Potential in the Healthcare Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $47.42..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Anticipating a 25.56% Upside Amid Market Volatility

GE HealthCare Technologies Inc. (GEHC), a prominent player in the healthcare sector, operates within the medical devices industry and is based in the United States. With..

Waters Corporation (WAT) Stock Analysis: Uncovering a 31.57% Potential Upside

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector’s Diagnostics & Research industry, presents a compelling opportunity for investors seeking growth in innovative analytical..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 21.5% Potential Upside

Koninklijke Philips N.V. (NYSE: PHG), a leading player in the healthcare sector and the medical devices industry, is catching the eye of investors with a notable..

AbbVie Inc. (ABBV) Stock Analysis: Strong Buy Ratings and Upside Potential Amidst Healthcare Innovations

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, stands out not only for its solid market cap of $406.87 billion but also for..

Agilent Technologies, Inc. (A) Stock Analysis: Unlocking a 40% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector with a focus on diagnostics and research, presents an intriguing opportunity for investors. With..

Novartis AG (NVS) Stock Analysis: Navigating Mixed Ratings and Dividend Appeal

Novartis AG (NYSE: NVS), a titan in the global healthcare sector, continues to draw investor attention with its robust pharmaceutical portfolio and strategic focus on innovation...

Centene Corporation (CNC) Stock Analysis: Navigating a Complex Healthcare Landscape with a Promising 2.55% Upside

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare sector, a key industry that continues to evolve amidst regulatory shifts and demographic changes...

Bristol-Myers Squibb (BMY) Stock Analysis: A Healthcare Giant with a Solid Dividend Yield and Strong ROE

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable presence in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $122.78..

Veeva Systems Inc. (VEEV) Investor Outlook: Evaluating the 40.89% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare sector, particularly in the specialized niche of health information services. Based in Pleasanton,..

Intuitive Surgical, Inc. (ISRG): Investor Outlook with 24.41% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector specializing in medical instruments and supplies, is attracting interest from investors with its compelling growth..

UnitedHealth Group (UNH) Stock Report: Evaluating a 27% Upside Amidst Robust Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, with a commanding market capitalization of $260.03 billion. As a diversified healthcare company..

Royalty Pharma plc (RPRX) Growth Potential: A Deep Dive into Analyst Ratings and Valuation Metrics

Royalty Pharma plc (NASDAQ: RPRX) has carved out a unique niche in the biotechnology sector by operating as a buyer of biopharmaceutical royalties and a funder..

United Therapeutics Corporation (UTHR): Analyst Consensus Reveals 22% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, particularly in the specialty and generic drug manufacturing space. With a market capitalization..

AstraZeneca PLC (AZN) Stock Analysis: Evaluating Growth Potential with a 22.84% ROE

AstraZeneca PLC (AZN) remains a formidable player in the global healthcare sector, with its expansive portfolio of prescription medicines targeting a wide array of diseases. Based..

Fresenius Medical Care AG (FMS) Stock Analysis: Uncovering an 18.45% Potential Upside Amidst Industry Challenges

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bad Homburg,..

Zoetis Inc. (ZTS) Stock Analysis: A 24.35% Potential Upside in the Animal Health Sector

Investors looking for growth opportunities in the healthcare sector may want to take a closer look at Zoetis Inc. (NYSE: ZTS). As a leader in the..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Giant with 14.46% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, particularly within the medical distribution industry. With a robust market capitalization of..

STERIS plc (STE) Stock Analysis: 22% Potential Upside Amid Robust Revenue Growth

STERIS plc (NYSE: STE), a prominent player in the healthcare sector, is capturing investor attention with a promising potential upside of 22.01%. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds